BCR signaling is a major driver of cell survival and proliferation in CLL and other B-cell malignancies, including diffuse large B-cell lymphoma (DLBCL) and Burkitt's lymphoma (BL) [24], [25], [26]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.